FDA Adverse Event Death Summary report: N

ENDEAVOR SPRINT RX

MDR report key: 4222398 · Received November 4, 2014

Report

Report Number
9612164-2014-01411
Event Type
Death
Date Received
November 4, 2014
Date of Event
March 16, 2014
Report Date
December 19, 2014
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVALUATION RESULTS: INHERENT RISK OF PROCEDURE ¿ (DEATH). EVALUATION CONCLUSIONS: INHERENT RISK OF PROCEDURE ¿ (DEATH). (B)(4).

Description of Event or Problem · 1

DEATH DEATH OCCURRED 53 MONTHS POST INDEX PROCEDURE AND NOT 55 MONTHS AS PREVIOUSLY REPORTED. CLINICAL EVALUATIONS COMMITTEE ADJUDICATED PATIENT DEATH AS NON-CARDIAC.

Description of Event or Problem · 1

DURING THE INDEX PROCEDURE, ONE ENDEAVOR SPRINT DRUG ELUTING STENT WAS USED TO TREAT THE TARGET LESION IN THE LEFT CX. IT WAS REPORTED THAT 55 MONTHS POST INDEX PROCEDURE, THE PATIENT PASSED AWAY IN HOSPICE CARE AFTER SUFFERING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). CAUSE OF DEATH LISTED AS COPD. INVESTIGATOR ASSESSED THE EVENT AS NOT RELATED TO STUDY DEVICE OR PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
708005 ENDEAVOR SPRINT RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 00072 YR Death